Elucidating the molecular mechanisms regulating osteoclasts, particularly the RANKL/RANK/OPG pathway, is essential for expanding our understanding of osteoporosis pathogenesis and identifying novel treatment targets. This evidence concerns the gene TNFSF11 and osteoporosis.